Leading resuscitation experts collaborate to improve SCA survival rates.
The HeartRescue Project is focused on developing and expanding SCA response systems by coordinating measurement, education, training and the application of evidence-based best practices among the general public, first responders, emergency medical services (EMS) and hospitals.
Every person who suffers sudden cardiac arrest (SCA) will receive lifesaving, state-of-the-art care at the scene, en route and in the hospital.
HeartRescue: Improving Access to Acute Cardiovascular Care
Launched in the United States in 2011, Medtronic Philanthropy's HeartRescue Project began as multi-state collaborative program to improve sudden cardiac arrest (SCA) survival rates. Today, with impressive results in more than six states, the effort is now expanding in the U.S. – and in China and India to expand life-saving emergency interventions for other heart-related events.
HeartRescue partners works toward integrating community response efforts, coordinating public and professional education about acute cardiac events such as SCA, and introducing and applying best practice treatments. It also helps hospitals implement a method for measuring SCA performance and outcomes.
HeartRescue fosters local ownership of each country program, by engaging multi-sector stakeholders, including governments, medical professional societies, local healthcare providers, patients, and families. The goal is to strengthen systems of care to enable people that have experienced an acute cardiovascular (CV) event as a result of underlying cardiovascular disease (CVD) to survive, and go on to successfully manage their condition over the long term.
In addition, by effectively addressing acute care for ischemic heart disease (the largest contributor to overall cardiovascular death rates), the potential exists to lessen the overall burden of CVD, strengthen the overall systems of care in the geographies served, and improve patient outcomes and quality of life.
Early results in the US are promising with statewide program coverage now passing 90% of the total population in most states, and many communities and regions reporting 50% to 300% increases in SCA survival rates.
In the US, HeartRescue Project leadership will transfer to the University of Washington, a founding partner, and expand nationally as the HeartRescue United States Consortium. Medtronic Philanthropy will continue funding these advances. Expansion efforts in Shanghai, China and Bangalore, India are now underway as HeartRescue also expands to emerging markets.